 <h1>Namzaric Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>donepezil / memantine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about donepezil / memantine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Namzaric.</p><h2>In Summary</h2><p><b>Common side effects of Namzaric include:</b> diarrhea. <b>Other side effects include:</b> dizziness, nausea, vomiting, anorexia, and ecchymoses.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to donepezil / memantine: oral capsule extended release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, donepezil/memantine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking donepezil / memantine:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Bloody or black, tarry stools</li>
<li>chest pain or discomfort</li>
<li>decreased urination</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>pain in the lower abdomen, groin, upper back or sides</li>
<li>seizures</li>
<li>severe stomach pain</li>
<li>slow or irregular heartbeat</li>
<li>sweating</li>
<li>trouble breathing</li>
<li>unusual tiredness</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of donepezil / memantine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Constipation</li>
<li>decreased appetite</li>
<li>diarrhea</li>
<li>nausea</li>
<li>vomiting</li>
</ul><p>
<!-- end oral capsule extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to donepezil / memantine: oral capsule extended release, oral kit</i></p><h3>Cardiovascular</h3><p>Memantine:</p>
<p><b>Common</b> (1% to 10%): Hypertension, hypotension</p>
<p><b>Postmarketing reports</b>: Congestive cardiac failure</p>
<p></p>
<p>Donepezil:</p>
<p><b>Common</b> (1% to 10%): Hypertension, hemorrhage, syncope</p>
<p><b>Postmarketing reports</b>: Heart block (all types)<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Memantine:</p>
<p><b>Common</b> (1% to 10%): Headache, dizziness, somnolence</p>
<p></p>
<p>Donepezil:</p>
<p><b>Common</b> (1% to 10%): Headache, dizziness, somnolence</p>
<p><b>Postmarketing reports</b>: Convulsions, neuroleptic malignant syndrome<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Memantine:</p>
<p><b>Common</b> (1% to 10%): Diarrhea, constipation, abdominal pain, vomiting</p>
<p><b>Postmarketing reports</b>: Pancreatitis</p>
<p></p>
<p>Donepezil:</p>
<p><b>Very common</b> (10% or more): Diarrhea (10%)</p>
<p><b>Common</b> (1% to 10%): Vomiting, anorexia, nausea</p>
<p><b>Postmarketing reports</b>: Abdominal pain, pancreatitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Memantine:</p>
<p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions in patients receiving memantine ER were headache, diarrhea, and dizziness.  The most common adverse reactions in patients receiving donepezil were diarrhea, anorexia, vomiting, nausea, and ecchymosis.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Memantine:</p>
<p><b>Postmarketing reports</b>: Stevens Johnson Syndrome</p>
<p></p>
<p>Donepezil:</p>
<p><b>Common</b> (1% to 10%): Eczema</p>
<p><b>Postmarketing reports</b>: Rash<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Memantine:</p>
<p><b>Postmarketing reports</b>: Agranulocytosis, leukopenia (including neutropenia), pancytopenia, thrombocytopenia, thrombotic thrombocytopenic purpura</p>
<p></p>
<p>Donepezil:</p>
<p><b>Common</b> (1% to 10%): Ecchymosis</p>
<p><b>Postmarketing reports</b>: Hemolytic anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Memantine:</p>
<p><b>Postmarketing reports</b>: Hepatitis</p>
<p></p>
<p>Donepezil:</p>
<p><b>Postmarketing reports</b>: Cholecystitis, hepatitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Donepezil:</p>
<p><b>Common</b> (1% to 10%): Increased creatinine phosphokinase, dehydration, hyperlipidemia</p>
<p><b>Postmarketing reports</b>: Hyponatremia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Memantine:</p>
<p><b>Common</b> (1% to 10%): Back pain</p>
<p></p>
<p>Donepezil:</p>
<p><b>Common</b> (1% to 10%): Back pain<sup>[Ref]</sup></p><h3>Other</h3><p>Memantine:</p>
<p><b>Common</b> (1% to 10%): Increased weight</p>
<p></p>
<p>Donepezil:</p>
<p><b>Very common</b> (10% or more): Accident (13%), infection (11%)</p>
<p><b>Common</b> (1% to 10%): Fever, pain, chest pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Memantine:</p>
<p><b>Common</b> (1% to 10%): Anxiety, depression, aggression</p>
<p><b>Postmarketing reports</b>: Suicidal ideation</p>
<p></p>
<p>Donepezil:</p>
<p><b>Common</b> (1% to 10%): Insomnia, nervousness, hallucinations, hostility, depression, confusion, emotional lability, personality disorder</p>
<p><b>Postmarketing reports</b>: Agitation, confusion, hallucinations<sup>[Ref]</sup></p><h3>Renal</h3><p>Memantine:</p>
<p><b>Common</b> (1% to 10%): Urinary incontinence</p>
<p><b>Postmarketing reports</b>: Acute renal failure</p>
<p></p>
<p>Donepezil:</p>
<p><b>Common</b> (1% to 10%): Urinary incontinence<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Namzaric (donepezil-memantine)." Forest Pharmaceuticals, St. Louis, MO. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Namzaric (donepezil / memantine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>5 Reviews</li>
<li>Drug class: cholinesterase inhibitors</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Namzaric &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Alzheimer's Disease</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to donepezil / memantine: oral capsule extended release, oral kit</i></p><h3>Cardiovascular</h3><p>Memantine:</p><p><b>Common</b> (1% to 10%): Hypertension, hypotension</p><p><b>Postmarketing reports</b>: Congestive cardiac failure</p><p></p><p>Donepezil:</p><p><b>Common</b> (1% to 10%): Hypertension, hemorrhage, syncope</p><p><b>Postmarketing reports</b>: Heart block (all types)<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Memantine:</p><p><b>Common</b> (1% to 10%): Headache, dizziness, somnolence</p><p></p><p>Donepezil:</p><p><b>Common</b> (1% to 10%): Headache, dizziness, somnolence</p><p><b>Postmarketing reports</b>: Convulsions, neuroleptic malignant syndrome<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Memantine:</p><p><b>Common</b> (1% to 10%): Diarrhea, constipation, abdominal pain, vomiting</p><p><b>Postmarketing reports</b>: Pancreatitis</p><p></p><p>Donepezil:</p><p><b>Very common</b> (10% or more): Diarrhea (10%)</p><p><b>Common</b> (1% to 10%): Vomiting, anorexia, nausea</p><p><b>Postmarketing reports</b>: Abdominal pain, pancreatitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Memantine:</p><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions in patients receiving memantine ER were headache, diarrhea, and dizziness.  The most common adverse reactions in patients receiving donepezil were diarrhea, anorexia, vomiting, nausea, and ecchymosis.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Memantine:</p><p><b>Postmarketing reports</b>: Stevens Johnson Syndrome</p><p></p><p>Donepezil:</p><p><b>Common</b> (1% to 10%): Eczema</p><p><b>Postmarketing reports</b>: Rash<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Memantine:</p><p><b>Postmarketing reports</b>: Agranulocytosis, leukopenia (including neutropenia), pancytopenia, thrombocytopenia, thrombotic thrombocytopenic purpura</p><p></p><p>Donepezil:</p><p><b>Common</b> (1% to 10%): Ecchymosis</p><p><b>Postmarketing reports</b>: Hemolytic anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Memantine:</p><p><b>Postmarketing reports</b>: Hepatitis</p><p></p><p>Donepezil:</p><p><b>Postmarketing reports</b>: Cholecystitis, hepatitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Donepezil:</p><p><b>Common</b> (1% to 10%): Increased creatinine phosphokinase, dehydration, hyperlipidemia</p><p><b>Postmarketing reports</b>: Hyponatremia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Memantine:</p><p><b>Common</b> (1% to 10%): Back pain</p><p></p><p>Donepezil:</p><p><b>Common</b> (1% to 10%): Back pain<sup>[Ref]</sup></p><h3>Other</h3><p>Memantine:</p><p><b>Common</b> (1% to 10%): Increased weight</p><p></p><p>Donepezil:</p><p><b>Very common</b> (10% or more): Accident (13%), infection (11%)</p><p><b>Common</b> (1% to 10%): Fever, pain, chest pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Memantine:</p><p><b>Common</b> (1% to 10%): Anxiety, depression, aggression</p><p><b>Postmarketing reports</b>: Suicidal ideation</p><p></p><p>Donepezil:</p><p><b>Common</b> (1% to 10%): Insomnia, nervousness, hallucinations, hostility, depression, confusion, emotional lability, personality disorder</p><p><b>Postmarketing reports</b>: Agitation, confusion, hallucinations<sup>[Ref]</sup></p><h3>Renal</h3><p>Memantine:</p><p><b>Common</b> (1% to 10%): Urinary incontinence</p><p><b>Postmarketing reports</b>: Acute renal failure</p><p></p><p>Donepezil:</p><p><b>Common</b> (1% to 10%): Urinary incontinence<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Namzaric (donepezil-memantine)." Forest Pharmaceuticals, St. Louis, MO. </p><h2>More about Namzaric (donepezil / memantine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>5 Reviews</li>
<li>Drug class: cholinesterase inhibitors</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Namzaric &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Alzheimer's Disease</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>